Sen. Wyden Requests Drug Pricing Law Implementation Information
February 03, 2023
February 03, 2023
WASHINGTON, Feb. 3 -- Sen. Ron Wyden, D-Oregon, chairman of the Senate Finance Committee, issued the following news release and letter:
Senate Finance Committee Chair Ron Wyden, D-Ore., asked the Biden administration to share key information with the public about the implementation of the Inflation Reduction Act's drug pricing provisions, specifically the price gouging penalties on drug companies known as inflation rebates, which apply to Medicare Parts B and D.
"I . . .
Senate Finance Committee Chair Ron Wyden, D-Ore., asked the Biden administration to share key information with the public about the implementation of the Inflation Reduction Act's drug pricing provisions, specifically the price gouging penalties on drug companies known as inflation rebates, which apply to Medicare Parts B and D.
"I . . .